Zentalis Pharmaceuticals reported Q1 2026 financial results with operating expenses at $28.7 million ...
Zentalis Pharmaceuticals entwickelt innovative Therapien ...
Die Aktie von Zentalis Pharmaceuticals steht im Fokus nachdem ...